Related Experiment Video
Updated: Mar 8, 2026

06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
7.1K
Mesenchymal Cells in Colon Cancer
Vasiliki Koliaraki1, Charles K Pallangyo2, Florian R Greten3
1Biomedical Sciences Research Centre "Alexander Fleming," Vari, Greece.
Gastroenterology
|January 24, 2017
Summary
Intestinal mesenchymal cells support gut health and are crucial in colorectal cancer development. Understanding their role in inflammation and cancer offers new therapeutic targets.
Area of Science:
- Gastroenterology
- Oncology
- Cell Biology
Background:
- Intestinal mesenchymal cells are diverse, supporting gut structure and homeostasis.
- These cells play critical roles in intestinal development and function.
- Recent research highlights their significance in colorectal cancer (CRC) and colitis-associated cancer.
Purpose of the Study:
- To review intestinal mesenchymal cell biology.
- To focus on their roles in inflammation and carcinogenesis.
- To explore therapeutic strategies targeting these cells in cancer.
Main Methods:
- Review of human transcriptome studies.
- Analysis of animal models for colitis-associated cancer.
- Examination of cancer-associated fibroblast (CAF) functions.
Main Results:
- Mesenchymal cells are vital for intestinal organogenesis, morphogenesis, and homeostasis.
- Cancer-associated fibroblasts (CAFs) promote colon tumor development via inflammation, proliferation, angiogenesis, and metastasis.
- Mesenchymal cells mediate interactions between inflammation and carcinogenesis.
Conclusions:
- Intestinal mesenchymal cells, particularly CAFs, are key drivers of colorectal cancer progression.
- Targeting mesenchymal cell pathways could offer novel therapeutic approaches for colitis-associated cancers.
- Further understanding of mesenchymal cell biology is essential for CRC treatment strategies.
Related Concept Videos
Mesenchymal Stem Cells
5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
Renewal of Intestinal Stem Cells
3.4K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.4K

